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General experimental 
 
All chromatographic separations1 were performed on Silica, 10-18, 60A, ICN Biomedicals. Standard 
techniques were used for the purification of reagents and solvents.2 Indium was obtained from Aldrich 
(cat. No. 277959, 99.99% pure, with 1% Mg as anticaking agent). NMR spectra were recorded on a 
Varian Gemini 200, (1H NMR at 200 MHz, 13C NMR at 50 MHz, for samples in deuterated chloroform), 
and on Bruker Avance III 500 (1H NMR at 500 MHz, 13C NMR at 125 MHz). Chemical shifts are 
expressed in ppm (δ) using tetramethylsilane as internal standard, coupling constants (J) are in Hz. IR 
spectra were recorded on a Nicolet 6700 FT instrument, and are expressed in cm-1. Mass spectra 
were obtained on Agilent technologies 6210 TOF LC/MS instrument (LC: series 1200). Microanalyses 
were performed at the Vario EL III instrument CHNOS Elementar Analyzer, Elementar 
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Analysensysteme GmbH, Hanau-Germany. Melting points were determined on a Kofler hot-stage 
apparatus and are uncorrected. 1-Tosyl-1H-indole-3-carbaldehyde3 and enantiomerically pure 2,3,4,5-
tetra-O-acetyl-D-arabinose4 were prepared according to literature procedures. 
 
X-ray crystal structure determination 
 
A single colorless crystal was selected and glued on glass fiber. Diffraction data were collected on an 
Oxford Diffraction KM4 four-circle goniometer equipped with Sapphire CCD detector. The crystal to 
detector distance was 45.0 mm and a graphite monochromated MoKα (λ = 0.71073 Å) X-radiation 
was employed in the measurements. The frame widths of 1° in ω, with 19 and 27 s were used to 
acquire each frame. More than a hemisphere of three-dimensional data was collected in all 
measurements. The data were reduced using the Oxford Diffraction program CrysAlisPro. A 
semiempirical absorption-correction based upon the intensities of equivalent reflections was applied, 
and the data were corrected for Lorentz, polarization, and background effects. Scattering curves for 
neutral atoms, together with anomalous-dispersion corrections, were taken from International Tables 
for X-ray Crystallography.5 The structures were solved by direct methods,6 and the figures were drawn 
using MERCURY.7 Refinements were based on F2 values and done by full-matrix least-squares8 with 
all non-H atoms anisotropic. The positions of all non H-atoms were located by direct methods. The 
positions of hydrogen atoms were found from the inspection of the difference Fourier maps. The final 
refinement included atomic positional and displacement parameters for all non-H atoms. The non-H 
atoms were refined anisotropically. However, at the final stage of the refinement, H atoms belonging 
to molecules were positioned geometrically (O−H = 0.82 and C−H = 0.93-0.97 Å) and refined using a 
riding model with fixed isotropic displacement parameters. 
 
4-Methyl-1,3-dioxol-2-one 
O
O
O
O O
O O
OH
CCl3Cl3C +
PhNMe2
C2H4Cl2
 
This compound was obtained in two steps, from hydroxyacetone, according to the modified literature 
procedure described for the preparation of the 4,5-dimethyl derivative.9 Triphosgene (3.0 g; 11 mmol) 
was added to a cold (0 °C) solution of hydroxyacetone (2.1 g; 28 mmol) in dichloroethane (20 mL), 
followed by a dropwise addition of N,N-dimethylaniline (3.7 g; 4 mL; 30 mmol), while maintaining 
temperature below 8 °C.The reaction mixture was stirred for 15 min at 0 °C, then two more hours at rt. 
The reaction mixture was cooled to 5 °C, washed with cold 3 M aqueous hydrochloric acid (40 mL), 
water (30 mL) and brine (30 mL), dried over anh. MgSO4, filtered and concentrated under reduced 
pressure to the half of the initial volume. The residue was heated to reflux for three hours. The solvent 
was completely removed at rotavap, and the remaining oil was heated in a stream of argon to 170 °C, 
for two and half hours, when considerable darkening occurs. The crude mixture was distilled under 
reduced pressure, to give 1.4 g (52%) of 4-methyl-1,3-dioxol-2-one, bp 130-140 °C/30 mmHg, as a 
light-yellow oil. Although the compound has been mentioned in the literature,10 no spectral data were 
given: IRfilm: 3169, 2934, 1828, 1801, 1124, 1071. 1H NMR: 6.84 (q, J=1.6, H); 2.13 (d, J=1.6, 3H). 13C 
NMR: 153.4 (C); 141.1 (C); 126.0 (CH); 9.7 (CH3). Anal. calcd. for C4H4O3: C 48.00; H 4.00; found: C 
47.93; H 4.16. 
 
4-(Bromomethyl)-1,3-dioxol-2-one 1 
O
O
O
Br
O
O
O
+ N
O
O
Br AIBN
CCl4
 
 
This compound was obtained according to the literature procedure.11 A mixture of 4-methyl-1,3-dioxol-
2-one (1 g; 10 mmol), N-bromosuccinimide (2.3 g; 13 mmol), azo-bis-isobutyronitrile (AIBN; 10 mg) 
and carbon tetrachloride (40 mL) was heated to reflux for 1.5 h. The reaction mixture was 
concentrated to the half of the initial volume, filtered, concentrated at rotavap and distilled under 
reduced pressure, to give 1.3 g (72%) of 4-(bromomethyl)-1,3-dioxol-2-one 1, as a light-yellow oil, bp 
100-110 °C/1 mmHg). No 13C NMR data are provided in the literature, and the literature 1H NMR was 
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recorded in CCl4: IRfilm: 3169, 2934, 1828, 1801, 1124, 1071. 1H NMR (CDCl3): 7.12 (t, J=1.2, H), 4.19 
(d, J=1.2, 2H) 13C NMR: 153.4 (C); 141.1 (C); 126.0 (CH); 9.7 (CH3). Anal. calcd. for C4H3BrO3: C 
26.82; H 1.68; Found: C 26.74; H 1.81. 
 
Due to a ban on the use of carbon tetrachloride, the possibility of using other solvents was 
investigated. The reaction could be performed in an analogous way in 1,2-dichloroethane: under 
these conditions 4-(bromomethyl)-1,3-dioxol-2-one 1 was obtained in 49% yield. 
 
General procedure for the allylation of carbonyl compounds with 4-(bromomethyl)-1,3-dioxol-
2-one 1 
 
Indium-promoted allylation 
 
O
O
O
Br
RCHO +
In
THF
R
OH
O
O
O
H2O
 
 
Aldehyde (0.19 mmol) was added to a mixture of 1 (50 mg; 0.28 mmol), indium (32.1 mg; 0.28 mmol), 
THF (0.5 mL) and water (1 mL), and the reaction mixture was stirred at rt. The reaction was monitored 
by TLC (eluent: 20% acetone in petroleum-ether) and it was usually complete after 15 min. The 
reaction mixture was diluted with dichloromethane (5 mL) and water (5 mL), the aqueous layer was 
extracted with dichloromethane (2 x 5 mL), combined organic extracts were dried over anh. MgSO4, 
filtered, concentrated under reduced pressure and the crude product was purified by dry-flash 
chromatography. 
 
Zinc-promoted allylation 
O
O
O
Br
RCHO +
Zn
THF
R
OH
O
O
O
NH4Cl
H2O  
Aldehyde (0.09 mmol) was added to a mixture of 1 (50 mg; 0.28 mmol), zinc (23 mg; 0.36 mmol), THF 
(0.2 mL) and saturated aqueous solution of NH4Cl (0.8 mL), and the reaction mixture was stirred at rt. 
The reaction was monitored by TLC (eluent: 20% acetone in petroleum-ether) and it was usually 
complete after 30 min. Work-up as previously described provided the crude product, which was 
purified by dry-flash chromatography. 
 
4-(Hydroxy(phenyl)methyl)-5-methylene-1,3-dioxolan-2-one 2a 
O
O
O
OH
2a
 
According to the general procedure for the indium-mediated allylation, starting from benzaldehyde 
(19.7 mg, 19 µL, 0.19 mmol); after purification by column chromatography (eluent: 20% acetone in 
hexanes), 37.7 mg (96%) of the title compound 2a was obtained, as a mixture of diastereoisomers in 
a ratio anti:syn=12:1. Recrystallization from 5% EtOAc in hexanes afforded white crystals of pure 2a-
anti, mp 70-71 °C. FT-IR (KBr): 3477, 3064, 2891, 1832, 1690, 1341, 1280, 1147, 1062, 766, 708. 1H 
NMR δ: 7.43-7.31 (m, 5H), 5.28 (ddd, J1=4.1, J2=2.3, J3=1.7, 1H), 5.14 (bt, J=4.1, 1H), 4.78 (dd,  
J1=3.9, J2=2.3, 1H), 3.87 (dd, J1=3.9, J2=1.7, 1H), 2.78 (d, J=4.1, 1H). 13C NMR δ: 152.3 (C), 148.6 
(C), 136.1 (C), 128.7 (CH), 128.6 (CH), 126.4 (CH), 89.7 (CH2), 82.3 (CH), 73.4 (CH). HRMS (ESI): 
calcd. for [C11H10O4 + NH4+]: 224.0923, found for [M+NH4]+: 224.0911. Anal. calcd. for C11H10O4: C 
64.08, H 4.85; found: C 63.81, H 4.73. 
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4-(Hydroxy(2-methoxyphenyl)methyl)-5-methylene-1,3-dioxolan-2-one 2b 
 
 
According to the general procedure for the indium-mediated allylation, starting from 2-methoxy-
benzaldehyde (38 mg, 0.28 mmol); purification by column chromatography (eluent: 20% acetone in 
petroleum-ether) afforded 38 mg (57%) of 2b-anti, followed by 29 mg (39%) of 2b-syn (Combined 
yield: 63.4 mg; 96%). Physical data for 2b-anti: recrystallized from 5% EtOAc in hexanes, white solid, 
mp 106-108 °C. FT-IR (KBr): 3487, 3011, 2969, 1809, 1690, 1492, 1346, 1248, 1158, 1054, 756. 1H 
NMR δ: 7.48-7.46 (m, 1H), 7.35-7.32 (m, 1H), 7.01 (td, J1=7.9, J2=0.7, 1H), 6.90 (dd, J1=7.9, J2=1.3, 
1H), 5.42 (ddd, J1=3.3, J2=2.2, J3=1.5, 1H), 5.38 (dd, J1=5.7, J2=3.3, 1H), 4.76 (dd, J1=3.7 J2=2.2, 1H), 
3.87 (s, 3H), 3.68 (dd, J1=3.7, J2=1.5, 1H), 3.02 (d, J=5.7, 1H). 13C NMR δ: 155.7 (C), 152.7 (C), 
149.0 (C), 129.6 (CH), 128.0 (CH), 124.1 (C), 120.7 (CH), 110.1 (CH), 89.3 (CH2), 80.5 (CH), 69.5 
(CH), 55.4 (CH3). HRMS (ESI): calcd. for [C12H12O5 + NH4+]: 254.1028, found for [M+NH4]+: 254.1026. 
Anal. calcd. for C12H12O5: C 61.02, H 5.08; found: C 60.68; H 5.14. Physical data for 2b-syn: 
recrystallized from 5% EtOAc in hexanes, white solid, mp 80 °C. FT-IR (KBr): 3462, 3072, 2970, 
1807, 1684, 1603, 1493, 1463, 1359, 1236, 1164, 1084, 1050, 848, 763. 1H NMR δ: 7.44 (dd, J1=7.8, 
J2=1.5, 1H), 7.36-7.32 (m, 1H), 7.02 (td, J1=7.8, J2=0.7, 1H), 6.93-6.91 (m, 1H), 5.36 (ddd, J1=3.7, 
J2=2.0, J3=1.7, 1H), 5.17 (dd, J1=6.0, J2= 3.7, 1H), 4.90 (dd, J1=3.9, J2=2.0, 1H), 4.25 (dd, J1=3.9, 
J2=1.7, 1H), 3.87 (s, 3H), 2.82 (d, J=6.0, 1H). 13C NMR δ: 156.1 (C), 152.1 (C), 151.0 (C), 129.8 (CH), 
128.0 (CH), 125.3 (C), 121.0 (CH), 110.5 (CH), 87.7 (CH2), 81.5 (CH), 71.1 (CH), 55.5 (CH3). HRMS 
(ESI): calcd. for C12H12O5: 236.0685, found for [M]+: 236.0677. Anal. calcd. for C12H12O5: C 61.02, H 
5.08; found: C 60.77, H 5.26. 
 
4-(Hydroxy(4-methoxyphenyl)methyl)-5-methylene-1,3-dioxolan-2-one 2c 
 
According to the general procedure for the indium-mediated allylation, starting from 4-methoxy-
benzaldehyde (25.8 mg, 23 μl, 0.19 mmol); purification by column chromatography (eluent: 20% 
acetone in petroleum-ether) afforded 36.6 mg (82 %) of the title compound 2c, as a mixture of 
diastereoisomers in a ratio anti:syn=8:1 (the ratio of diastereoisomers did not change after 
crystallization from 5% EtOAc in hexanes). White crystals, m.p. 60-2 °C. Spectral data for 2c: FT-IR 
(KBr): 3478, 3013, 2960, 1828, 1690, 1514, 1250, 1145, 1055, 849, 764. 1H NMR δ: 7.29 (d, J=9.0, 
2H), 6.90 (d, J=9.0, 2H), 5.25 (ddd, J1=4.0, J2=2.2, J3=1.8, 1H), 5.03 (bt, J1=4.0, 1H), 4.81 (dd, J1=3.4, 
J2=2.2, 1H), 3.95 (dd, J1=3.4, J2=1.8, 1H), 3.80 (s, 3H), 3.26 (d, J=4.0, 1H). 13C NMR δ: 159.8 (C), 
148.8 (C), 128.5 (C), 128.2 (C), 127.8 (CH), 113.9 (CH), 89.5 (CH2), 82.3 (CH), 73.2 (CH), 55.2 (CH3). 
HRMS (ESI): calcd. for [C12H12O5 + Na+]: 259.0582, found for [M+Na]+: 259.0577. 
 
4-(Benzo[d][1,3]dioxol-5-yl(hydroxy)methyl)-5-methylene-1,3-dioxolan-2-one 2d 
 
According to the general procedure for the indium-mediated allylation, starting from piperonal (28 mg, 
0.19 mmol); purification by column chromatography (eluent: 20% acetone in petroleum-ether) afforded 
45.2 mg (95%) of the title compound 2d, as a mixture of diastereoisomers in a ratio anti:syn=6:1. 
White crystals (recrystallized from 10% EtOAc in petroleum-ether), m.p. 103-4 °C. Spectral data for 
2d: FT-IR (KBr): 3455, 3020, 2909, 1825, 1695, 1499, 1338, 1246, 1160, 1062, 1036, 931, 865, 742. 
1H NMR δ: 6.89-6.82 (m, 3H), 5.99 (bs, 2H), 5.21 (ddd, J1=4.2, J2=2.3, J3=1.9, 1H), 5.00 (bt, J=4.2, 
1H), 4.87 (dd, J1=3.8, J2=2.3, 1H), 4.05 (dd, J1=3.8, J2=1.9, 1H), 2.51 (bd, J=4.2, 1H). 13C NMR δ: 
152.0 (C), 148.8 (C), 148.0 (C), 148.0 (C), 130.1 (C), 120.1 (CH), 108.4 (CH), 106.9 (CH), 101.4 
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(CH2), 89.8 (CH2), 82.0 (CH), 73.6 (CH). HRMS (ESI): calcd. for [C12H10O6 + Na+]: 273.0375, found for 
[M+Na]+: 273.0356. Anal. calcd. for C12H10O6: C 57.60, H 4.00; found: C 57.29, H 4.25. 
 
4-((4-Chlorophenyl)(hydroxy)methyl)-5-methylene-1,3-dioxolan-2-one 2e 
 
According to the general procedure for the indium-mediated allylation, starting from 4-chloro-
benzaldehyde (33 mg, 0.23 mmol); purification by column chromatography (eluent: 30% acetone in 
petroleum-ether) afforded 52.8 mg (96%) of the title compound 2e, as a mixture of diastereoisomers 
in a ratio anti:syn=7:1. Monocrystal of pure 2e-anti, suitable for X-ray crystallographic analysis, was 
obtained by crystallization from 5% EtOAc in hexanes. Physical data for 2e-anti: white, crystalline 
compound, mp 88-90 °C. FT-IR (KBr): 3847, 3075, 2983, 1816, 1691, 1342, 1154, 1062, 871, 744. 1H 
NMR δ: 7.39 (d, J=8.5, 2H), 7.34 (d, J=8.5, 2H), 5.24 (ddd, J1=4.4, J2=2.0, J3=1.8, 1H), 5.11 (bt, 
J=4.4, 1H), 4.84 (dd, J1=4.0, J2=2.0, 1H), 3.91 (dd, J1=4.0, J2=1.8, 1H), 2.96 (d, J=4.4, 1H). 13C NMR 
δ: 152.2 (C), 148.4 (C), 134.7 (C), 134.6 (C), 128.8 (CH), 127.9 (CH), 89.9 (CH2), 82.0 (CH), 72.9 
(CH). HRMS (ESI): calcd. for [C11H9O4Cl + Na+]: 263.0087, found for [M+Na]+: 263.0083. Anal. calcd. 
for C11H9O4Cl: C 54.88, H 3.74; found: C 54.67, H 3.79. 
 
4-(Hydroxy(1-tosyl-1H-indol-3-yl)methyl)-5-methylene-1,3-dioxolan-2-one 2f 
N
Ts
O
O
OH
O2f  
According to the general procedure for the indium-mediated allylation, starting from 1-tosyl-1H-indole-
3-carbaldehyde (23 mg, 77 μmol); purification by column chromatography (eluent: 20% acetone in 
petroleum-ether) afforded 23 mg (78%) of the title compound 2f. Physical data for 2f: pale-yellow oil, 
FT-IR (film): 3483, 3058, 2927, 1833, 1690, 1447, 1370, 1274, 1173, 1126, 1065, 744, 674, 574. 1H 
NMR δ: 8.03 (d, J=8.4, 1H), 7.78 (d, J=7.8, 2H), 7.86 (s, 1H), 7.53 (d, J=7.8, 1H), 7.41-7.22 (m, 4H), 
5.35 (bs, 2H), 4.78-4.76 (m, 1H), 3.79-3.76 (m, 1H), 2.77 (bs, 1H), 2.35 (s, 3H). 13C NMR δ: 152.2 (C), 
148.3 (C), 145.4 (C), 135.2 (C), 134.7 (C), 130.0 (C), 127.7 (C), 126.9 (CH), 125.4 (CH), 125.2 (CH), 
123.7 (CH), 119.4 (CH), 118.3 (CH), 114.0 (CH),  89.8 (CH2), 80.6 (CH), 68.4 (CH), 21.5 (CH3). 
HRMS (ESI): calcd. for [C20H17NO6S + Na+]: 422.0674, found for [M+Na]+: 422.0683. 
 
4-(Furan-2-yl(hydroxy)methyl)-5-methylene-1,3-dioxolan-2-one 2g 
 
According to the general procedure for the indium-mediated allylation, starting from furane-2-
carbaldehyde (18.2 mg, 0.19 mmol); purification by column chromatography (eluent: 20% acetone in 
petroleum-ether) afforded 21 mg (56%) of 2g-anti, followed by 10 mg (27%) of 2g-syn (combined 
yield: 83%). Physical data for 2g-anti: colorless oil. FT-IR (film): 3460, 2925, 1827, 1692, 1345, 1271, 
1144, 1061, 859, 749. 1H NMR δ: 7.45 (dd, J1=1.9, J2=0.9, 1H), 6.46-6.45 (m, J1=3.3, J2=0.9, 1H), 
6.42 (dd, J1=3.3, J2=1.9, 1H), 5.45 (ddd, J1=3.7, J2=2.2, J3=2.0, 1H), 5.08 (ddd, J1=6.8, J2=3.7, J3=0.7, 
1H), 4.90 (dd, J1=3.9, J2=2.2, 1H), 4.10 (dd, J1=3.9, J2=2.0, 1H), 2.57 (d, J=6.8, 1H). 13C NMR δ: 
151.8 (C), 149.8 (C), 148.5 (C), 143.0 (CH), 110.8 (CH), 109.1 (CH), 89.5 (CH2), 80.2 (CH), 68.9 
(CH). HRMS (ESI): calcd. for [C9H8O5 + CH3COO-]: 255.0505, found for [M+CH3COO]-: 255.0518. 
Physical data for 2g-syn: colorless oil. FT-IR (film): 3461, 2926, 1823, 1692, 1352, 1278, 1148, 1072, 
860, 747. 1H NMR δ: 7.45 (dd, J1=1.8, J2=1.0, 1H), 6.48 (dt, J1=2.6, J2=1.0, 1H), 6.42 (dd, J1=2.6, 
J2=1.8, 1H), 5.42 (ddd, J1=4.9, J2=2.3, J3=2.0, 1H), 4.93 (dd, J1=4.2, J2=2.3, 1H), 4.91 (t, J=4.9, 1H), 
4.22 (dd, J1=4.2, J2=2.0, 1H), 2.56 (d, J=4.9, 1H). 13C NMR δ: 151.6 (C), 149.9 (C), 149.6 (C), 143.2 
(CH), 110.8 (CH), 109.6 (CH), 88.8 (CH2), 80.1 (CH), 69.1 (CH). HRMS (ESI): calcd. for [C9H8O5 + 
HCOO-]: 241.0348, found for [M+HCOO]-: 241.0358. 
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4-(Hydroxy(thiophen-2-yl)methyl)-5-methylene-1,3-dioxolan-2-one 2h 
 
According to the general procedure for the indium-mediated allylation, starting from thiophene-2-
carbaldehyde (21 mg, 0.19 mmol); purification by column chromatography (eluent: 20% acetone in 
petroleum-ether) afforded 36.5 mg (91%) of 2h, as a mixture of diastereoisomers in a ratio 
anti:syn=6.4:1. 
Physical data for 2h: pale-yellow oil, FT-IR (film): 3462, 3111, 3023, 1828, 1691, 1346, 1273, 1145, 
1057, 856, 709. 1H NMR δ: 7.34 (dd, J1=1.8, J2=1.6, 1H), 7.09-7.02 (m, 2H), 5.36-5.27 (m, 2H), 4.88 
(dd, J1=3.6, J2=1.9, 1H), 4.12 (dd, J1=3.6, J2=1.6, 1H), 3.29 (d, J=5.0, 1H). 13C NMR δ: 152.1 (C), 
148.5 (C), 139.6 (C), 127.3 (CH), 126.1 (CH), 125.4 (CH), 89.9 (CH2), 81.9 (CH), 70.8 (CH). HRMS 
(ESI): calcd. for [C9H8O4S + Na+]: 235.0041, found for [M+Na]+: 235.0027. 
 
4-(1-Hydroxyheptyl)-5-methylene-1,3-dioxolan-2-one 2i 
n-C6H11
O
O
O
OH
2i  
According to the general procedure for the indium-mediated allylation, starting from heptanal (16 mg, 
0.14 mmol); purification by column chromatography (eluent: 20% acetone in petroleum-ether) afforded 
26.4 mg (88%) of 2i, as an unseparable mixture of diastereoisomers in a ratio anti:syn=6:1. Physical 
data for 2i: colorless oil, FT-IR (film): 3479, 2930, 2856, 1831, 1690, 1463, 1348, 1157, 1069. 1H NMR 
δ: 5.04 (ddd, J1=3.8, J2=2.2, J3=1.9, 1H), 4.97 (dd, J1=3.8, J2=2.2, 1H), 4.49 (dd, J1=3.8, J2=1.9, 1H), 
3.84 (s, 1H), 2.42 (s, 1H), 1.58-1.54 (m, 2H), 1.36-1.30 (m, 8H), 0.89 (t, J=6.8, 3H). 13C NMR δ: 152.3 
(C), 149.9 (C), 89.0 (CH2), 82.0 (CH), 72.0 (CH), 31.6 (CH2), 31.0 (CH2), 29.0 (CH2), 25.3 (CH2), 22.5 
(CH2), 14.0 (CH3). HRMS (ESI): calcd. for [C11H18O4 + NH4+]: 232.1549, found for [M+NH4]+: 
232.1531. 
 
(E)-4-(1-Hydroxybut-2-en-1-yl)-5-methylene-1,3-dioxolan-2-one 2j 
 
According to the general procedure for the indium-mediated allylation, starting from crotonaldehyde 
(13 mg, 0.19 mmol), purification by column chromatography (eluent: 20% acetone in petroleum-ether) 
afforded 26.4 mg (82%) of 2j, as an unseparable, equimolar mixture of diastereoisomers. Physical 
data for 2j: colorless oil, FT-IR (film): 3464, 3025, 2920, 1825, 1690, 1448, 1348, 1276, 1146, 1067, 
971. 1H NMR δ:  5.96-5.88 (m, 2H, anti, syn), 5.55 (ddq, J1=15.0, J2=3.0, J3=1.5, 1H, anti), 5.49 (ddq, 
J1=15.5, J2=3.5, J3=1.8, 1H, syn), 5.09 (ddd, J1=5.5, J2=3.0, J3=1.5, 1H, syn), 5.07 (ddd, J1=4.3, 
J2=2.5, J3=1.3, 1H, anti), 4.95 (dd, J1=2.3, J2=1.5, 1H, anti), 4.94 (dd, J1=2.3, J2=1.3, 1H, syn), 4.52 
(dd, J1=3.0, J2=2.3, 1H, anti), 4.47 (dd, J1=2.5, J2=2.3, 1H, syn), 4.39 (bs, 1H, syn), 4.28 (bdd, J1=3.0, 
J2=4.3, 1H, anti), 2.45 (bs, 1H, syn), 2.30 (bs, 1H, anti), 1.78-1.76 (m, 6H, anti, syn). 13C NMR δ: 2j-
anti: 152.1 (C), 150.2 (C), 132.9 (CH), 126.3 (CH), 88.4 (CH2), 81.2 (CH), 73.4 (CH), 17.8 (CH3); 2j-
syn: 152.2 (C), 149.4 (C), 131.9 (CH), 125.4 (CH), 89.0 (CH2), 81.7 (CH), 72.8 (CH), 17.8 (CH3). 
HRMS (ESI): calcd. for [C8H10O4 + NH4+]: 188.0923, found for [M+NH4]+: 188.0914. 
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(E)-4-(1-hydroxy-3-phenylallyl)-5-methylene-1,3-dioxolan-2-one 2k 
 
According to the general procedure for the indium-mediated allylation, starting from cinnamaldehyde 
(25 mg, 0.19 mmol), purification by column chromatography (eluent: 30% acetone in petroleum-ether) 
afforded 40 mg (91%) of 2k, as an unseparable mixture of diastereoisomers in a ratio anti:syn=1.4:1. 
Physical data for 2k: colorless oil, FT-IR (film): 3466, 3027, 1828, 1690, 1344, 1274, 1147, 1066, 973, 
859, 754. 1H NMR δ: 7.40-7.28 (m, 10H), 6.79 (dd, J1=16.0, J2=1.3, 1H, anti), 6.77 (d, J=16.0, 1H, 
syn), 6.24 (dd, J1=16.0, J2=7.5, 1H, syn), 6.15 (dd, J1=16.0, J2=5.5, 1H, anti), 5.18-5.15 (m, 2H, anti, 
syn), 4.98 (dd, J1=3.8, J2=2.3, 1H, syn), 4.95 (dd, J1=4.0, J2=2.0, 1H, anti), 4.66-4.64 (m, 1H, anti), 
4.55 (dd, J1=3.8, J2=1.8, 1H, syn), 4.50 (ddd, J1=7.5, J2=3.8, J3=1.3, 1H, syn), 4.48 (dd, J1=4.0, 
J2=2.0, 1H, anti), 2.63 (bs, 1H), 2.45 (bs, 1H). 13C NMR δ: 2k-anti: 152.1 (C), 149.1 (C), 135.5 (CH), 
128.7 (CH), 128.6 (CH), 128.5 (C), 126.7 (CH), 123.2 (CH), 89.3 (CH2), 81.5 (CH), 72.7 (CH); 2k-syn: 
152.0 (C), 150.0 (C), 128.7 (CH), 128.6 (C), 128.5 (CH), 126.8 (CH), 134.5 (CH), 123.9 (CH), 88.7 
(CH2), 81.3 (CH), 73.6 (CH). HRMS (ESI): calcd. for [C13H12O4 + NH4+]: 250.1079, found for [M+NH4]+: 
250.1070. 
 
4-(2-(Benzyloxy)-1-hydroxyethyl)-5-methylene-1,3-dioxolan-2-one 2l 
 
According to the general procedure for the indium-mediated allylation, starting from 
benzyloxyacetaldehyde (10 mg, 67 μmol), purification by column chromatography (eluent: 20% 
acetone in petroleum-ether) afforded 12.2 mg (76%) of 2l, as an unseparable mixture of syn and anti 
diastereoisomers in a ratio anti:syn=3:1, as determined by HPLC analysis. Physical data for 2l: pale-
yellow oil, FT-IR (film): 3457, 3064, 3030, 2922, 2870, 1832, 1690, 1454, 1328, 1272, 1147, 1061, 
858, 747, 700. 1H NMR δ: 7.46-7.32 (m, 5H), 5.22 (dd, J1=2.6, J2=4.8, 1H, syn), 5.17 (ddd, J1=1.7, 
J2=3.9, J3 =5.6, 1H, anti), 4.94-4.92 (m, 2H, anti, syn), 4.57-4.50 (m, 3H), 4.43 (dd, J1=1.7 Hz, J2=3.9 
Hz, 1H, anti), 3.99-3-97 (m, 2H, anti, syn), 3.68-3.62 (m, 2H), 2.67 (bs, 1H, anti), 2.47 (bs, 1H, syn). 
13C NMR δ: 152.0 (C), 150.7 (C), 150.0 (C), 137.0 (C), 128.6 (CH), 128.2 (CH), 128.2 (CH), 128.1 
(CH), 128.0 (CH), 128.0 (CH), 89.4 (CH2, anti), 87.7 (CH2, syn), 79.0 (CH, syn), 78.6 (CH, anti), 73.7 
(CH2), 71.2 (CH, syn), 70.4 (CH, anti), 69.2 (CH2, syn), 68.8 (CH2, anti). HRMS (ESI): calcd. for 
[C13H14O5 + Na+]: 273.0739,  found for [M+Na]+: 273.0738. 
 
(2R,3R,4R,5S)-5-hydroxy-5-((S)-5-methylene-2-oxo-1,3-dioxolan-4-yl)pentane-1,2,3,4-tetrayl 
tetraacetate 2m 
 
According to the general procedure for the indium-mediated allylation, starting from peracetyl 
arabinose (63.7 mg; 0.2 mmol); purification by dry-flash chromatography afforded 50 mg (60%) of the 
title compound 2m. Colorless crystals, mp 102-5 °C (from petroleum ether/ethyl acetate). αD +11 (c 
0.2, CHCl3). FT-IR (KBr): 3469, 2975, 1834, 1745, 1690, 1372, 1216, 1148, 1055. 1H NMR δ: 5.42 
(dd, J1=1.2, J2=10, 1H), 5.26 (dd, J1=1.2, J2=10, 1H), 5.08 (t, J=2.8, 1H), 5.00-5.04 (m, 1H), 4.90-4.98 
(m, 2H), 4.26 (d, J=2.8, 2H), 4.02 (m, 1H), 3.68-3.79 (m, 1H), 2,23 (s, 3H), 2.14 (s, 3H), 2.08 (s, 3H), 
2.06 (s, 3H). 13C NMR δ: 172.3 (C), 170.5 (C), 170.2 (C), 169.8 (C), 152.1 (C), 148.6 (C), 90.1 (CH2), 
78.8 (CH), 68.7 (CH), 68.6 (CH), 67.9 (CH), 67.3 (CH), 61.4 (CH2), 20.7 (CH3), 20.7 (CH3), 20.6 
(CH3), 20.5 (CH3). Anal. calcd. for C17H22O12: C 48.81, H 5.30; found: C 48.58, H 5.27. 
 
S9 
 
 
(S)-Tert-butyl 4-((R)-hydroxy((R)-5-methylene-2-oxo-1,3-dioxolan-4-yl)methyl)-2,2-
dimethyloxazolidine-3-carboxylate 2n (SRR), and (S)-Tert-butyl 4-((S)-hydroxy((S)-5-methylene-
2-oxo-1,3-dioxolan-4-yl)methyl)-2,2-dimethyloxazolidine-3-carboxylate 2n (SSS)  
 
 
According to the general procedure for the indium-mediated allylation, starting from 42 mg (0.18 
mmol) of the Garner aldehyde ((4S)-tert-butyl-4-formyl-2,2-dimethyloxazolidine-3-carboxylate); 
purification by dry-flash chromatography (SiO2, eluent: 30% acetone in petroleum-ether) afforded 49 
mg (81%) of the title product as an equimolar mixture of diastereoisomers 2n (SRR) and 2n (SSS). 
Crystallization from 20% acetone in hexanes afforded white crystals which were also a 1:1 
diastereoisomeric mixture. The isomers could be separated by rapid flash chromatography (SiO2, 
gradient elution: chloroform/MeOH from 99/1 to 97/3), where 2n (SRR) is a less polar and 2n (SSS) is 
the more polar isomer. Both isomers were submitted to X-ray crystallographic analysis, the results of 
which are graphically represented on pages S61 and S63.  
Physical data for 2n (SRR): White, rhombohedral crystals, mp 180-182 °C. FT-IR (KBr): 2924, 2853, 
1827, 1689, 1653, 1392, 1372, 1147, 1058, 863, 767. 1H NMR (d6-DMSO, 340 K ) δ: 5.61 (d, J=4.5, 
1H), 5.32 (ddd, J1=2.4, J2=2.2, J3=1.5, 1H), 4.90 (dd, J1=3.5, J2=2.2, 1H), 4.70 (dd, J1=3.5, J2=2.4, 
1H), 4.06 (br. t, J=6.5, 1H), 4.03 (dd, J1=9.5, J2=1.5, 1H), 3.96-3.91 (m, 2H), 1.54 (s, 3H), 1.42 (s, 3H), 
1.41 (s, 9 H). 13C NMR (d6-DMSO, 340 K) δ: 151.8 (C), 150.1 (C), 93.8 (C), 89.0 (CH2), 79.8 (CH), 
70.3 (CH), 63.5 (CH2), 57.9 (CH), 28.0 (CH3), 26.3 (CH3), 23.4 (CH3). HRMS (ESI): calcd. for 
[C15H23NO7 + Na+]: 352.1372, found for [M+Na]+: 352.1351. [α]D20 -37 (c 1.0, CHCl3). Physical data for 
2n (SSS): White, rod-like crystals, mp 114-116 °C. FT-IR (KBr): 3467, 2980, 2936, 1835, 1690, 1392, 
1373, 1149, 1059, 862, 768. 1H NMR (d6-DMSO, 343 K ) δ: 5.95 (s, 1H), 5.21 (ddd, J1=5.5, J2=3.5, 
J3=2.0, 1H), 4.95-4.89 (m, 2H), 4.09 (dd, J1=8.9, J2=1.4, 1H), 3.95 (ddd, J1=6.5, J2=1.4, J3=1.0, 1H), 
3.87 (dd, J1=8.9, J2=6.5, 1H), 3.76 (bs, 1H), 1.50 (s, 3H), 1.46 (s, 3H), 1.44 (s, 9H). 13C NMR (d6-
DMSO, 343 K) δ: 152.0 (C), 151.5 (C), 150.0 (C), 93.2 (C), 88.7 (CH2), 80.1 (C), 79.8 (CH), 70.6 
(CH), 62.9 (CH2), 56.6 (CH), 27.7 (CH3), 26.8 (CH3), 23.8 (CH3).HRMS (ESI): calcd. for [C15H23NO7 + 
Na+]: 352.1372, found for [M+Na]+: 352.1357. Anal. calcd. for C15H23NO7: C 54.71, H 6.99, N 4.25; 
found: C 54.39, H 6.73, N 4.04. 
 
4-(1-Hydroxycyclohexyl)-5-methylene-1,3-dioxolan-2-one 2o 
 
According to the general procedure for the indium-mediated allylation, starting from cyclohexanone 
(19.6 mg; 0.2 mmol); purification by dry-flash chromatography afforded 21 mg (52%) of the 2o. 
Colorless crystals, mp 107-9 °C (from hexanes/ethyl acetate). FT-IR (KBr): 3483, 2985, 2936, 2863, 
1798, 1686, 1345, 1159, 1049. 1H NMR δ: 5.00 (dd, J1=1.8, J2=4.0, 1H), 4.84 (t, J=1.8, 1H), 4.53 (dd, 
J1=1.6, J2=4.0, 1H), 1.42-1.72 (m, 10H), 1.21-1.28 (m, 1H). 13C NMR δ: 149.9 (C), 90.0 (C), 84.8 
(CH2), 72.4 (CH), 32.1 (CH2), 31.3 (CH2), 25.2 (CH2), 20.8 (CH2). Anal. calcd. for C10H14O4: C 60.59, 
H 7.12; found: C 60.50, H 7.11. 
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anti-Methyl 2-hydroxy-2-(5-methylene-2-oxo-1,3-dioxolan-4-yl)propanoate 2p and trans-methyl 
5-acetyl-4-methyl-2-oxo-1,3-dioxolane-4-carboxylate 2q 
 
According to the general procedure for the indium-mediated allylation, starting from methyl pyruvate 
(18.2 mg; 0.18 mmol); purification by dry flash chromatography (gradient elution: from 20% to 30% 
acetone in petroleum-ether) afforded 19 mg (52%) of 2p, followed by 3 mg (8%) of 2q. 
Physical data for 2p: Colorless crystals, mp 93-5 °C (from hexanes/ethyl acetate). FT-IR (KBr): 3481, 
2959, 1832, 1740, 1689, 1336, 1267 1141, 1059. 1H NMR δ: 5.17 (m, 1H), 5.00 (dd, J1=3.4, J2=4.0, 
1H), 4.58 (dd, J1=1.8, J2=4.0, 1H), 3.87 (s, 3H), 3.64 (s, 1H), 1.53 (s, 3H). 13C NMR δ: 173.5 (C), 
151.6 (C), 148.9 (C), 90.2 (CH2), 81.4 (CH), 75.1 (C), 53.8 (CH3), 21.3 (CH3). HRMS (ESI): calcd. for 
[C8H10O6 + Na+]: 225.0369; found for [M+Na]+: 225.0368. Physical data for 2q: Colorless oil. FT-IR 
(film): 2962, 1827, 1741, 1692, 1445, 1273, 1225, 1113, 1078. 1H NMR δ: 5.10 (s, 1H), 3.91 (s, 3H), 
2.36 (s, 1H), 1.58 (s, 3H). 13C NMR δ: 201.6 (C), 168.9 (C), 151.9 (C), 148.9 (C), 85.6 (C), 82.5 (CH), 
54 (CH3), 28.0 (CH3), 18.5 (CH3). HRMS (ESI) calcd. for C8H11O6 [M+H]+: 302.0550; found: 203.0549. 
 
General procedure for the deprotection of enol carbonates 2 into α,β-dihydroxy ketones 3 
 
R
O
O
OH
O
1. Hg(NO3)2
2. KI, H2O
H2O, dioxane R
OH O
OH
2 3  
Mercury(II) nitrate (118 mg; 0.364 mmol) was added to a cold (0 °C) solution of compound 2 (0.121 
mmol) in dioxane (2 mL) and water (0.6 mL). The reaction mixture was stirred for 5 min, when TLC 
(eluent: 50% EtOAc in petroleum-ether) indicated the disappearance of the starting material. 
Saturated aqueous solution of KI (10 mL) was added at 0 °C, the mixture was allowed to reach rt, and 
was stirred at rt for an additional 5 min. Standard work-up with diethyl ether, followed by purification 
by dry-flash chromatography, afforded the pure compound 3. 
 
anti-3,4-Dihydroxy-4-phenylbutan-2-one 3a12 
 
According to the general procedure for the deprotection of enol carbonates, starting from 2a (25 mg, 
0.12 mmol); after purification by column chromatography (eluent: 50% EtOAc in hexanes), 14.6 mg 
(67%) of the title compound 3a was obtained, as a mixture of isomers in a ratio anti:syn=12:1 (the 
ratio of isomers did not change after crystallization from 5% EtOAc in hexanes). Physical data for 3a: 
White crystals, m.p. 106-7 °C. FT-IR (KBr): 3417, 3032, 2916, 1712, 1357, 1231, 1101, 1055, 759, 
704. 1HNMR δ: 7.42-7.31 (m, 5H), 5.02-4.98 (m, 1H), 4.46 (bt, J1 = 4.4, 1H), 3.74 (d, J = 4.4, 1H), 
3.12 (d, J = 4.4, 1H), 1.95 (s, 3H). 13C NMR δ: 208.2 (C), 138.9 (C), 128.6 (CH), 128.2 (CH), 126.2 
(CH), 81.1 (CH), 74.9 (CH), 27.6 (CH3). HRMS (ESI): calcd. for [C10H12O3 + NH4+]: 198.1130, found 
for [M+NH4]+: 198.1124. 
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anti-3,4-Dihydroxy-4-(4-methoxyphenyl)butan-2-one 3c13 
 
According to the general procedure for the deprotection of enol carbonates, starting from 2c (43.5 mg, 
0.18 mmol); after purification by column chromatography (eluent: 50% EtOAc in petroleum-ether), 25 
mg (64%) of the title compound 3c was obtained, as a mixture of diastereoisomers in a ratio: 
anti:syn=10:1. Physical data for 3c: white crystals, mp 50-3 °C (recrystallized from 5% EtOAc in 
hexanes), FT-IR (KBr): 3429, 3004, 2913, 1712, 1514, 1357, 1249, 1178, 1031, 836. 1H NMR δ: 7.32 
(d, J=8.8, 2H), 6.90 (d, J=8.8, 2H), 4.93 (d, J=4.8, 1H), 4.43 (d, J=4.8, 1H), 3.81 (s, 3H), 3.67 (bd, 
J=4.8, 1H), 3.05 (bs, 1H), 2.00 (s, 3H). 13C NMR δ: 208.4 (C), 159.4 (C), 131.0 (C), 127.5 (CH), 113.9 
(CH), 80.9 (CH), 74.5 (CH), 55.2 (CH3), 27.6 (CH3). HRMS (ESI): calcd. for [C11H14O4 + NH4+]: 
228.1236, found for [M+NH4]+: 228.1225. 
 
anti-4-(Benzo[d][1,3]dioxol-5-yl)-3,4-dihydroxybutan-2-one 3d 
 
According to the general procedure for the deprotection of enol carbonates, starting from 2d (72 mg, 
0.29 mmol); after purification by column chromatography (eluent: 50% EtOAc in petroleum-ether), 
31.6 mg (49%) of the title compound 3d was obtained, as a mixture of diastereoisomers in a ratio: 
anti:syn=6.4:1. Physical data for 3d: white crystals, mp 112-5 °C, FT-IR (KBr): 3426, 2902, 1713, 
1490, 1444, 1358, 1247, 1037, 930. 1H NMR δ: 6.92-6.77 (m, 3H), 5.97 (s, 2H), 4.88 (bt, J=3.9, 1H), 
4.40 (t, J=4.9, 1H), 3.59 (d, J=4.9, 1H), 2.93 (d, J=3.9, 1H), 2.06 (s, 3H). 13C NMR δ: 208.3 (C), 147.9 
(C), 147.5 (C), 133.0 (C), 119.8 (CH), 108.2 (CH), 106.8 (CH), 101.2 (CH2), 80.8 (CH), 74.7 (CH), 
27.6 (CH3). HRMS (ESI): calcd. for [C11H12O5 + Na+]: 247.0582, found for [M+Na]+: 247.0573. 
 
anti-3,4-Dihydroxy-4-(4-chlorophenyl)butan-2-one 3e14 
 
According to the general procedure for the deprotection of enol carbonates, starting from 2e 
(30 mg, 0.13 mmol); after purification by column chromatography (eluent: 50% EtOAc in petroleum-
ether), 20.1 mg (75%) of the title compound 3e was obtained, as unseparable mixture of 
diastereoisomers in a ratio: anti:syn=7.7:1. Physical data for 3e: white crystals, mp 52-4 °C, FT-IR 
(KBr): 3416, 3032, 2919, 1712, 1358, 1231, 1102, 1056, 759, 705. 1H NMR δ: 7.39-7.29 (m, 4H), 4.96 
(bs, 1H), 4.42 (bt, J=4.8, 1H), 3.75 (d, J=4.8, 1H), 3.19 (bs, 1H), 1.98 (s, 3H). 13C NMR δ: 207.9 (C), 
137.6 (C), 134.0 (C), 128.7 (CH), 127.6 (CH), 80.8 (CH), 74.3 (CH), 27.7 (CH3). HRMS (ESI): calcd. 
for [C10H11O3Cl + Na+]: 237.0294, found for [M+Na]+: 237.0290. Anal. calcd. for C10H11O3Cl: C 55.94, 
H 5.13; found: C 55.98, H 5.08. 
 
anti-3,4-Dihydroxydecan-2-one 3i 
 
According to the general procedure for the deprotection of enol carbonates, starting from 2i (18 mg, 
0.08 mmol); after purification by column chromatography (eluent: 50% EtOAc in petroleum-ether), 10 
mg (67%) of the title compound 3i was obtained. Physical data for 3i: white crystals, mp 50-2 °C (from 
5% EtOAc in hexanes), FT-IR (KBr): 3303, 3210, 2926, 2852, 1719, 1361, 1080, 1053. 1H NMR δ: 
4.28 (t, J=5.2, 1H), 3.88 (bs, 1H), 3.51 (d, J=5.2, 1H), 2.26 (s, 3H), 2.08 (d, J=7.5, 1H), 1.53-1.49 (m, 
2H), 1.28-1.27 (m, 8H), 0.88 (t, J=7.0, 3H). 13C NMR δ: 208.0 (C), 80.5 (CH), 72.7 (CH), 31.8(CH2), 
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31.7 (CH2), 29.1 (CH2), 26.9 (CH3), 25.6 (CH2), 22.6 (CH2), 14.0 (CH3). HRMS (ESI): calcd. for 
[C10H20O3 + Na+]: 211.1310, found for [M+Na]+: 211.1307. 
 
 
General procedure for the rearrangement of enol carbonates 2 into cis cyclic carbonates 4 
 
Diisopropylethylamine (6 mg; 8.0 µL; 46 µmol) was added to a solution of compound 2 (0.083 mmol) 
in chloroform (1.5 mL). Reaction mixture was stirred at rt, and the progress of the reaction was 
monitored by TLC (eluent: 40% EtOAc in petroleum-ether; the reactions are usually complete in 1-3 
h). The reaction mixture was concentrated at rotavap and the crude product purified by dry-flash 
chromatography. 
 
cis-4-Acetyl-5-phenyl-1,3-dioxolan-2-one 4a 
   
According to the general procedure for the rearrangement of enol carbonates 2 into cis cyclic 
carbonates 4, starting from 2a (20 mg; 97 µmol); purification by column chromatography (eluent: 50% 
EtOAc in petroleum-ether) afforded 14.1 mg (71%) of the title compound 4a. Physical data for 4a: 
white crystals, mp 106-7 oC, FT-IR (KBr): 3429, 3047, 2980, 1809, 1721, 1339, 1173, 1074, 768. 1H 
NMR δ: 7.42-7.40 (m, 3H); 7.26-7.25 (m, 2H); 5.92 (d, J=8.8, 1H); 5.23 (d, J=8.8, 1H); 1.77 (s, 3H). 
13C NMR δ: 153.7 (C), 148.5 (C), 131.9 (C), 130.0 (CH), 129.1 (CH), 126.1 (CH), 82.5 (CH), 79.4 
(CH), 27.6 (CH3). HRMS (ESI): calcd. for [C11H10O4 + Na+]: 229.0477, found for [M+Na]+: 229.0477. 
 
cis-4-Acetyl-5-(4-methoxyphenyl)-1,3-dioxolan-2-one 4c 
OO
O
O
MeO 4c  
According to the general procedure for the rearrangement of enol carbonates 2 into cis cyclic 
carbonates 4, starting from 2c (25 mg; 0.106 mmol); purification by column chromatography (eluent: 
50% EtOAc in petroleum-ether) afforded 14 mg (56%) of the title compound 4c. Physical data for 4c: 
white crystals, mp 130-132 °C. IR (KBr): 2974, 2841, 1790, 1726, 1617, 1519, 1340, 1260, 1175, 
1173, 835, 767. 1H NMR δ: 7.18 (d, J=9.0, 2H); 6.91 (d, J=9.0, 2H); 5.88 (d, J=8.7, 1H); 5.21 (d, 
J=8.7, 1H); 3.81 (s, 3H), 1.80 (s, 3H). 13C NMR δ: 201.9 (C), 160.7 (C), 153.7 (C), 127.6 (CH), 123.7 
(C), 114.5 (CH), 82.6 (CH), 79.4 (CH), 55.3 (CH3), 27.7 (CH3). HRMS (ESI): calcd. for [C12H12O5 + 
Na+]: 259.0582, found for [M+Na]+: 259.0571. Anal. calcd. for C12H12O5: C 61.02, H 5.08; found: C 
60.50, H 5.08. 
 
cis-4-Acetyl-5-(benzo[d][1,3]dioxol-5-yl)-1,3-dioxolan-2-one 4d 
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According to the general procedure for the rearrangement of enol carbonates 2 into cis cyclic 
carbonates 4, starting from 2d (43 mg; 0.172 mmol); purification by column chromatography (eluent: 
50% EtOAc in petroleum-ether) afforded 22.7 mg (53%) of the title compound 4d. Physical data for 
4d: white crystals, mp 136-8 °C (5% EtOAc in hexanes), FT-IR (KBr): 3437, 2908, 1794, 1725, 1502, 
1261, 1180, 1075, 812, 767. 1H NMR δ: 6.82 (d, J=8.0, 1H); 6.74 (dd, J1=8.0, J2=2.0, 1H); 6.70 (d, 
J=2.0, 1H); 6.00 (s, 2H); 5.82 (d, J=8.8, 1H); 5.19 (d, J=8.8, 1H); 1.88 (s, 3H). 13C NMR δ: 201.7 (C), 
153.5 (C), 149.0 (C), 148.4 (C), 125.4 (C), 120.2 (CH), 108.7 (CH), 106.4 (CH), 101.7 (CH2), 82.4 
(CH), 79.4 (CH), 27.8 (CH3). HRMS (ESI): calcd. for [C12H10O6 + NH4+]: 268.0821, found for [M+NH4]+: 
268.0817; Anal. calcd. for C12H10O6: C 57.60, H 4.00; found: C 57.28, H 4.25. 
 
cis-4-Acetyl-5-(4-chlorophenyl)-1,3-dioxolan-2-one 4e 
 
According to the general procedure for the rearrangement of enol carbonates 2 into cis cyclic 
carbonates 4, starting from 2e (20 mg; 0.08 mmol); purification by column chromatography (eluent: 
50% EtOAc in petroleum-ether) afforded 12.6 mg (63%) of the title compound 4e. Physical data for 
4e: white crystals, mp 102-3 °C, FT-IR (KBr): 3438, 3004, 2922, 1793, 1341, 1179, 1075, 814. 1H 
NMR δ: 7.40 (d, J=8.8, 2H); 7.20 (d, J=8.8, 2H); 5.89 (d, J=9.0, 1H); 5.21 (d, J=9.0, 1H); 1.85 (s, 3H). 
13C NMR δ: 201.8 (C), 153.3 (C), 136.2 (C), 130.5 (C), 129.4 (CH), 127.4 (CH), 82.3 (CH), 78.7 (CH), 
27.8 (CH3). HRMS (ESI): calcd. for [C11H9O4Cl + NH4+]: 258.0533, found for [M+NH4]+: 258.0532. 
Anal. calcd. for C11H9O4Cl: C 54.88, H 3.74; found: C 54.60, H 3.90. 
 
cis-4-Acetyl-5-hexyl-1,3-dioxolan-2-one 4i 
 
 
According to the general procedure for the rearrangement of enol carbonates 2 into cis cyclic 
carbonates 4, starting from 2i (17 mg, 0.08 mmol); purification by column chromatography (eluent: 
50% EtOAc in petroleum-ether) afforded 10 mg (59%) of the title compound 4i, as a colorless oil. 
Physical data for 4i: FT-IR (KBr): 2956, 2930, 2859, 1812, 1727, 1463, 1363, 1166, 1080. 1H NMR δ: 
4.61 (q, J=6.2, 1H), 4.47 (d, J=6.2, 1H), 2.36 (s, 3H), 1.84-1.79 (m, 2H), 1.56-1.29 (m, 8H), 0.89 (t, 
J=6.8, 3H). 13C NMR δ: 204.0 (C), 153.3 (C), 83.0 (CH), 79.1 (CH), 34.6 (CH2), 31.4 (CH2), 28.6 
(CH2), 26.5 (CH3), 24.1 (CH2), 22.4 (CH2), 13.9 (CH3). HRMS (ESI) calcd. for [C11H18O4 + Na+]: 
237.1103; found for [M+Na]+: 237.1090. 
 
4-Acetyl-5-((E)-prop-1-en-1-yl)-1,3-dioxolan-2-one – mixture of cis isomer 4j and trans isomer 5j 
 
According to the general procedure for the rearrangement of enol carbonates 2 into cis cyclic 
carbonates 5, starting from 2j (20 mg; 0.28 mmol); purification by column chromatography (eluent: 
50% EtOAc in petroleum-ether) afforded 10 mg (50%) of 5j (trans), followed by 8 mg (40%) of 4j (cis). 
Physical data for 5j: colorless oil, FT-IR (film): 2922, 1804, 1726, 1356, 1174, 1078. 1H NMR δ: 6.06-
5.98 (m, 1H), 5.58 (ddq, J1=15.0, J2=6.9, J3=1.8, 1H), 5.01 (bt, J=6.9, 1H), 4.57 (d, J=6.9, 1H), 2.36 (s, 
3H), 1.80 (ddd, J1=7.0, J2=1.8, J3=0.5, 3H). 13C NMR δ: 202.7 (C), 153.0 (C), 135.0 (CH), 124.9 (CH), 
83.0 (CH), 79.3 (CH), 26.7 (CH3), 17.8 (CH3). HRMS (ESI): calcd. for [C8H10O4 + NH4]: 188.0923, 
found for [M+NH4]+: 188.0919. Physical data for 4j: colorless oil, FT-IR (film): 2928, 1799, 1723, 1337, 
1174, 1076. 1H NMR δ: 6.06-5.99 (m, 1H), 5.34-5.26 (m, 2H), 4.98 (d, J=8.5, 1H), 2.25 (s, 3H), 1.78-
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1.77 (m, 3H). 13C NMR δ: 202.4 (C), 153.4 (C), 135.8 (CH), 121.2 (CH), 81.4 (CH), 78.9 (CH), 28.2 
(CH3), 17.8 (CH3). HRMS (ESI): calcd. for [C8H10O4+ NH4+]: 188.0923, found for [M+NH4+]+: 188.0919. 
 
 
(E)-4-Acetyl-5-styryl-1,3-dioxolan-2-one - cis isomer 4k and trans isomer 5k 
 
According to the general procedure for the rearrangement of enol carbonates 2 into cis cyclic 
carbonates 4, starting from 2k (36 mg; 0.129 mmol); purification by column chromatography (eluent: 
50% EtOAc in petroleum-ether) afforded 16.3 mg (45%) of 5k, followed by 12.2 mg (34%) of 4k. 
Physical data for 4k: white crystals, mp 92-4 °C (from 5% EtOAc in hexanes), FT-IR (KBr): 3060, 
3029, 1808, 1730, 1336, 1171, 1082, 1024, 978, 757, 695. 1H NMR δ: 7.39-7.32 (m, 5H), 6.83 (dd, 
J1=15.7, J2=1.1, 1H), 5.96 (dd, J1=15.7, J2=7.3, 1H), 5.57-5.48 (m,1H), 5.10 (d, J=9.0, 1H), 2.27 (s, 
3H). 13C NMR δ: 202.5 (C), 153.3 (C), 137.0 (CH), 134.5 (C), 129.3 (CH), 128.8 (CH), 127.1 (CH), 
118.3 (CH), 81.4 (CH), 78.6 (CH), 28.3 (CH3). HRMS (ESI): calcd. for [C13H12O4 + K+]: 271.0373, 
found for [M+K]+: 271.0367. Physical data for 5k: white crystals, mp 115-6 °C (from 5% EtOAc in 
hexanes), FT-IR (KBr): 3028, 2923, 1810, 1729, 1358, 1170, 1090, 972, 758, 695. 1H NMR δ: 7.45-
7.33 (m, 5H), 6.83 (d, J=15.7, 1H), 6.20 (dd, J1=15.7, J2=7.4, 1H), 5.26 (t, J=6.2, 1H), 4.68 (d, J=6.2, 
1H), 2.41 (s, 3H). 13C NMR δ: 202.8 (C), 153.0 (C), 136.7 (CH), 134.6 (C), 129.3 (CH), 128.9 (CH), 
127.1 (CH), 121.9 (CH), 83.0 (CH), 79.2 (CH), 26.8 (CH3). HRMS (ESI): calcd. for [C13H12O4 + K+]: 
271.0373, found for [M+K]+: 271.0365. Anal. calcd. for C13H12O4: C 67.24, H 5.17; found: C 66.93, H 
5.32. 
 
(1S,2R,3R)-1-((4S,5S)-5-acetyl-2-oxo-1,3-dioxolan-4-yl)butane-1,2,3,4-tetrayl tetraacetate 4m 
 
According to the general procedure for the rearrangement of enol carbonates 2 into cis cyclic 
carbonates 4, starting from 2m (10 mg; 24 μmol); purification by column chromatography (eluent: 50% 
EtOAc in petroleum-ether) afforded 7.5 mg (75%) of the title compound 4m. Physical data for 4m: 
yellow oil, FT-IR (film): 3358, 2924, 2853, 2363, 1821, 1746, 1371, 1209, 1134, 1161, 736, 602. 1H 
NMR δ: 5.50-5.46 (m, 2H), 5.13-5.10 (m, 1H), 4.93 (d, J=4.6, 1H), 4.78 (t, J=4.6, 1H), 4.27 (dd, 
J1=13.0, J2=3.0, 1H), 4.08 (dd, J1=13.0, J2=4.8, 1H), 2.37 (s, 3H), 2.14 (s, 3H), 2.10 (s, 3H), 2.08 (s, 
3H), 2.08 (s, 3H). 13C NMR δ: 203.2 (C), 170.5 (C), 169.8 (C), 169.7 (C), 169.2 (C), 152.1 (C), 79.5 
(CH), 76.4 (CH), 69.2 (CH), 68.2 (CH), 67.8 (CH), 61.3 (CH2), 26.7 (CH3), 20.8 (CH3), 20.7 (CH3), 
20.6 (CH3), 20.4 (CH3). HRMS (ESI): calcd. for [C17H22O12 + NH4+]: 436.1455, found for [M+NH4]+: 
436.1449.  
 
 
General procedure for the rearrangement of enol carbonates 2 into trans cyclic carbonates 5 
 
Diisopropylethylamine (103 mg; 140 µL; 0.8 mmol) was added to a solution of compound 2 (0.16 
mmol) in chloroform (1.5 mL). Reaction mixture was stirred at rt, and the progress of the reaction was 
monitored by TLC (eluent: 40% EtOAc in petroleum-ether; the reactions are usually complete in 45 
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min). The reaction mixture was concentrated at rotavap and the crude product purified by dry-flash 
chromatography. 
 
trans-4-Acetyl-5-(benzo[d][1,3]dioxol-5-yl)-1,3-dioxolan-2-one 5d and 4-(benzo[d][1,3]dioxol-5-
yl)-4-hydroxybut-3-en-2-one 6d 
 
According to the general procedure for the rearrangement of enol carbonates 2 into trans cyclic 
carbonates 5, starting from 2d (40 mg; 0.16 mmol); purification by column chromatography (eluent: 
50% EtOAc in petroleum-ether) afforded 20 mg (50%) of the title compound 5d. When the reaction 
time was extended to several hours, in addition to 5d, compound 6d (a less polar spot on TLC) could 
also be isolated in 20% yield. This compound is described in the literature,15 and the copies of its' 1H 
and 13C NMR spectra are on pages S112 and S113. Physical data for 5d: white crystals, mp 102-5 
°C, FT-IR (KBr): 3360, 2924, 1803, 1730, 1659, 1498, 1452, 1256, 1169, 1080, 1036, 767. 1H NMR δ: 
6.86-6.83 (m, 3H), 6.01 (s, 2H), 5.55 (d, J=6.3, 1H), 4.72 (d, J=6.3, 1H), 2.40 (s, 3H). 13C NMR δ: 
202.8 (C), 148.9 (CH), 148.7 (C), 129.2 (C), 120.0 (CH), 108.8 (CH), 105.9 (CH), 101.7 (CH2), 84.8 
(CH), 79.4(CH), 26.9 (CH3); one carbon resonance, corresponding to the quaternary carbon atom 
from carbonate, was not observed under the recording conditions. HRMS (ESI): calcd. for [C12H10O6 + 
NH4+]: 268.0821, found for [M+NH4]+: 268.0810. Anal. calcd. for C12H10O6: C 57.60, H 4.00; found: C 
57.91, H 3.88. 
 
trans-4-Acetyl-5-(4-chlorophenyl)-1,3-dioxolan-2-one 5e 
OO
O
O
5e
Cl  
According to the general procedure for the rearrangement of enol carbonates 2 into trans cyclic 
carbonates 5, starting from 2e (20 mg; 80 μmol); purification by column chromatography (eluent: 50% 
EtOAc in petroleum-ether) afforded 12 mg (60%) of the title compound 5e. Physical data for 5e: white 
crystals, mp 92-3 °C (from 5% EtOAc in hexanes), FT-IR (KBr): 3424, 2920, 1815, 1718, 1164, 1095, 
761. 1H NMR δ: 7.43 (d, J=8.3, 2H), 7.34 (d, J=8.3, 2H), 5.66 (d, J=6.5, 1H), 4.69 (d, J=6.5, 1H), 2.43 
(s, 3H). 13C NMR δ: 202.8 (C), 152.7 (C), 135.8 (C), 134.2 (C), 129.6 (CH), 126.9 (CH),  84.6 (CH), 
78.5 (CH), 26.9 (CH3). HRMS (ESI): calcd. for [C11H9O4Cl + Na+]: 263.0087, found for [M+Na]+: 
263.0085. Anal. calcd. for C11H9O4Cl: C 54.88, H 3.74; found: C 54.47, H 3.58.  
 
 
                                                    
1 For description of the technique of dry-flash chromatography, see: a) Harwood, L. M. Aldrichimica Acta 1985, 
18, 25; b) Vogel’s Textbook of Practical Organic Chemistry, Longman Scientific&Technical, 5th edition, 
London, 1989, p. 220; c) An account which includes some improvements of the separation technique: Pedersen, 
D. S.; Rosenbohm, C. Synthesis 2001, 2431. 
2 Perrin, D. D.; Armarego, W. L. F. Purification of Laboratory Chemicals, 3rd edition, Pergamon Press, 1988. 
3 Synthesis of 1-Tosyl-1H-indole-3-carbaldehyde: Guo, X.; Hu, W.; Cheng, S.; Wang, L.; Chang, J. Synth. 
Commun. 2006, 36, 781. 
4 Wolfrom, M. L.; Weisblat, D. I.; Zophy, W. H.; Waisbrot, S. W. J. Am. Chem. Soc. 1941, 63, 201. 
5 Ibers, J. A.; Hamilton, W. C. International Tables for X-ray Crystallography, Kynoch Press, Birmingham, 
1974. 
6 SIR-92: Altomare, A.; Cascarano, G.; Giacovazzo, C.; Guagliardi, A. J. Appl. Cryst. 1993, 26, 343. 
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7 Mercury: visualization and analysis of crystal structures, Macrae, C. F.; Edgington, P. R.; McCabe, P.; 
Pidcock, E.; Shields, G. P.; Taylor, R.; Towler, M.; Van de Streek, J. J. Appl. Cryst. 2006, 39, 453. 
8 Sheldrick, M. SHELXL-97, Program for crystal structure refinement, University of Goettingen, Germany, 
1997. 
9 Alexander, J. U. S. Patent 5 466 811, 1995; Chem. Abstr. 1995, 124, 176148x. 
10 Jung, M.; Blum, R.; Gaede, B.; Gisler, M. Heterocycles, 1989, 28, 93 
11 a) Sakamoto, F.; Ikeda, S.; Tsukamoto, G. Chem. Pharm. Bull. 1984, 32, 2241. b) For the explanation of the 
mechanism of the reaction sequence, see: Fischler, H.-M.; Heine, H.-G.; Hartmen, W. Tetrahedron Lett. 1972, 
1701. 
12 a) Markert, M.; Mulzer, M.; Schetter, B., Mahrwald, R. J. Am. Chem. Soc. 2007, 129, 7258; b) Rogozinska, 
M.; Mlynarski, J. Tetrahedron Lett. 2009, 50, 1639. 
13 In the literature, this compound has not been characterized as a pure anti isomer, but as a mixture of 
diastereoisomers; therefore its’ spectral data are provided here. See: Aelvoet, K.; Batsanov, A. S.; Blatch, A. J.; 
Grosjean, C.; Patrick, L. G. F.; Smethurst, C. A.; Whiting, A. Angew. Chem. Int. Ed. 2008, 47, 768. 
14 Schetter, B.; Stosiek, C.; Ziemer, B.; Mahrwald, R. Appl. Organometal. Chem. 2007, 21, 139. 
15 a) M. Julia, M.; Jassonneix, C. B. Bull. Soc. Chim. Fr. 1975, 751; b) Mors, W.; Gottliee, O. R.; Djerassi, C. J. 
Am. Chem. Soc. 1957, 79, 4507. 
 
 

































































































